NEW YORK, NY–(Marketwired – November 19, 2015) – ICAP Patent Brokerage announces for sale patents disclosing the next generation in patient stabilization for traumatic injury — devices and methods for hemostasis, chest drainage, wound closure, maintenance of perfusion, portable limb traction, and control of contamination. This portfolio is available from Damage Control Surgical Technologies, Inc. as part of of ICAP Patent Brokerage’s December 2015 Cardiovascular Patent Auction. The live virtual auction will open for bidding on Tuesday, December 8th at 9 am PST and will have a bidding deadline of December 10th at 5 pm PST. The auction is a sealed bid format, and the highest value bids above reserve price will win each respective technology for sale.
Damage Control Surgical Technologies, Inc. is led by Jay Lenker, Ph.D., its Co-Founder, President and CEO. Dr. Lenker consulted and served as VP of Scientific Affairs for MicroVention, Inc., a startup company developing products for the treatment of cerebrovascular aneurysms and has consulted and has helped lead many startup companies in various capacities. See the inventor biography for Dr. Lenker here. Dr. Lenker has participated in a live Inventor Q&A session for this technology. A recording of this call can be found here.
“This portfolio covers numerous technologies helpful in stabilizing patients prior to receiving definitive care in attempts to improve patient outcomes,” says Peter Johnson, Sr. Vice President for all Medical transactions at ICAP Patent Brokerage. “It is an important portfolio for companies involved in general surgery, cardiothoracic surgery, vascular surgery, wound care, trauma surgery, combat medicine, emergency medical services, bone fracture, shunts, clamps, bandages, catheters, splints, surgical bolts and surgical packs.”
Key Characteristics & Benefits
Patients often need to be transported increased distances for definitive care. The technologies in this portfolio help stabilize patients prior to such transport. Such technologies include devices and methods for:
- Hemostasis
- Chest drainage
- Wound closure
- Maintenance of perfusion
- Portable limb traction
- Control of contamination
Damage control is a method triage involving patient stability that has been adopted by the military in many scenarios and can offer improved outcomes.
See the technical description of the Shunts, Clamps, Bandages, Catheters, Splints, Surgical Bolts & Packs IP sales offering.
Sample forward or rearward citing companies include Johnson & Johnson, Medtronic Plc, Honeywell International Inc., Abbott Laboratories.
To learn more about the intellectual property available for sale in this portfolio:
Contact Michelle Tyler of ICAP Patent Brokerage at (312) 327-4438 or via email at michelle(at)icapip(dot)com.
If you would like to sell or auction a patent portfolio, visit our website to make a patent portfolio submission:
http://icappatentbrokerage.com/auction/submitip/
Follow us on Twitter (@ICAP_IP) and join our LinkedIn group.
About ICAP Patent Brokerage
ICAP Patent Brokerage is the world’s largest intellectual property brokerage and patent auction firm, leveraging the talents of experienced patent brokers to match buyers and sellers for the sale of patents and other intellectual property assets. With multiple transaction platforms and unparalleled industry knowledge, including experience with trademarks, brands, intellectual property licensing, and UCC sales, ICAP Patent Brokerage is the global leader in the transaction of intellectual property.
Image Available: http://www.marketwire.com/library/MwGo/2015/11/19/11G072897/Images/cardio-Ad_11-16-15-3fdf36fc0d6dab4a97d317991b993e52.jpg
